Evidence map›Paper›PMID 38006037›Full record

ArticleVaccines2023

Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection.

Silvia D'Orso, Marta Pirronello, Alice Verdiani, Angelo Rossini, Gisella Guerrera, Mario Picozza, Manolo Sambucci, Andrea Misiti, Lorenzo De Marco, Antonino Salvia and 4 more

Abstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Silvia D'OrsoNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.
Marta PirronelloNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0002-9907-2279
Alice VerdianiNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.
Angelo RossiniMedical Services, Santa Lucia Foundation IRCCS, 00179 Rome, Italy.ORCID 0000-0002-0173-7325
Gisella GuerreraNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.
Mario PicozzaNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0002-2529-6456
Manolo SambucciNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0003-1124-7327
Andrea MisitiNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.
Lorenzo De MarcoNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.
Antonino SalviaMedical Services, Santa Lucia Foundation IRCCS, 00179 Rome, Italy.ORCID 0000-0001-7000-3424
Carlo CaltagironeDepartment of Clinical and Behavioral Neurology, Santa Lucia Foundation IRCCS, 00179 Rome, Italy.
Emiliano GiardinaGenomic Medicine Laboratory UILDM, Santa Lucia Foundation IRCCS, 00179 Rome, Italy.
Luca BattistiniNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0002-6488-4891
Giovanna BorsellinoNeuroimmunology Unit, Santa Lucia Foundation IRCCS, 00143 Rome, Italy.ORCID 0000-0002-4227-6481

Funding

Italian Ministry of Health COVID-2020-12371735
6 · The paper itself

Abstract

Breakthrough infections in SARS-CoV-2 vaccinated individuals are an ideal circumstance for the simultaneous exploration of both the vaccine-induced memory reaction to the spike (S) protein and the primary response to the membrane (M) and nucleocapsid (N) proteins generated by natural infection. We monitored 15 healthcare workers who had been vaccinated with two doses of Pfizer BioNTech BNT162b2 and were then later infected with the SARS-CoV-2 B.1.617.2. (Delta) variant, analysing the antiviral humoral and cellular immune responses. Natural infection determined an immediate and sharp rise in anti-RBD antibody titres and in the frequency of both S-specific antibody secreting cells (ASCs) and memory B lymphocytes. T cells responded promptly to infection by activating and expanding already at 2-5 days. S-specific memory and emerging M- and N-specific T cells both expressed high levels of activation markers and showed effector capacity with similar kinetics but with different magnitude. The results show that natural infection with SARS-CoV-2 in vaccinated individuals induces fully functional and rapidly expanding T and B lymphocytes in concert with the emergence of novel virus-specific T cells. This swift and punctual response also covers viral variants and captures a paradigmatic case of a healthy adaptive immune reaction to infection with a mutating virus.

Indexed as

adaptive immune responsebreakthrough infectionSARS-CoV-2vaccination

Identifiers

PMID38006037
PMCPMC10675240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.